Showing results (91-100 of 228) with videos related to
Sort By:
Pageof 23
Current Psychology (New Brunswick, N.J.)|June 26, 2023
Transitioning to college with ADHD: a qualitative examination of parental support and the renegotiation of the parent-child relationshipAnne E Stevens, Elizabeth K Lefler, Judah W Serrano, et al.Cytogenetics and Cell Genetics|January 1, 1986
Random acrocentric bivalent associations in human pachytene spermatocytes. Molecular implications in the occurrence of Robertsonian translocationsM R Guichaoua, M Devictor, M Hartung, et al.Journal of General Internal Medicine|April 20, 2005
Clinical implications of an accurate problem list on heart failure treatmentDaniel M Hartung, Jacquelyn Hunt, Joseph Siemienczuk, et al.Pharmacotherapy|September 28, 2005
Risk of hospitalization for heart failure associated with thiazolidinedione therapy: a medicaid claims-based case-control studyDaniel M Hartung, Daniel R Touchette, Nanette C Bultemeier, et al.Journal of Attention Disorders|August 9, 2015
Efficacy of an Organizational Skills Intervention for College Students With ADHD Symptomatology and Academic DifficultiesPatrick A LaCount, Cynthia M Hartung, Christopher R Shelton, et al.Neurology. Clinical Practice|September 26, 2022
Association Between Pharmacy Benefit Restrictions and Disease-Modifying Therapy Use in the Medicare Part D ProgramDaniel M Hartung, Kirbee A Johnston, Jessina C McGregor, et al.Bioorganic & Medicinal Chemistry Letters|November 4, 2015
A selective delta opioid receptor antagonist based on a stilbene coreAlyssa M Hartung, Hernan A Navarro, David F Wiemer, et al.Neurology|April 26, 2015
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?Daniel M Hartung, Dennis N Bourdette, Sharia M Ahmed, et al.Multiple Sclerosis and Related Disorders|October 8, 2020
The effect of out-of-pocket costs on initiation of disease-modifying therapies among medicare beneficiaries with multiple sclerosisDaniel M Hartung, Kirbee A Johnston, Jessina C McGregor, et al.Journal of Attention Disorders|August 3, 2016
Psychometric Properties of the Weiss Functional Impairment Rating Scale: Evidence for Utility in Research, Assessment, and Treatment of ADHD in Emerging AdultsWill H Canu, Cynthia M Hartung, Anne E Stevens, et al.Pageof 23